PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
53.94
ESG score below 80% of INKT's 68.97. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
52.44
Environmental score 80-90% of INKT's 59.45. Walter Schloss would scrutinize carbon exposure and transition planning.
56.52
Social score below 80% of INKT's 76.83. Jim Chanos would check for potential social license and litigation risks.
52.86
Governance score below 80% of INKT's 70.64. Jim Chanos would check for potential agency conflicts and oversight failures.